Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

A healthy diet can lower depression risk in older adults, despite genetics (opens in a new tab)

medicalxpress.com · 2026-10-21

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 2 other points were not covered by the paper.

  • 1 supported
  • 1 overstated
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. One of four checks out. Two claims the study doesn't address.

  • 1 supported
  • 1 overstated
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4OverstatedDeakin research has revealed that older adults can reduce their risk of depression by eating a healthy diet and that the benefits were evident regardless of a genetic predisposition to depression or existing low-grade inflammation.View evidenceHide evidence

Why this verdict

The abstract-level profile supports longitudinal associations: higher UPF intake was associated with higher risk of incident depressive symptoms, a higher anti-inflammatory diet score with lower risk, and no evidence of modification by PRS or hs-CRP. But the claim’s wording that older adults “can reduce their risk of depression by eating a healthy diet” is stronger and more causal/actionable than warranted for an observational target-trial emulation, and it shifts the outcome from depressive symptoms to depression. The “regardless of” modifier is directionally consistent with the reported null effect-modification findings, but the causal and clinical-diagnosis framing is overstated.

1

Study evidence

High ultra-processed food (UPF) consumption was associated with a higher risk of incident depressive symptoms during follow-up.RR 1.12 (95% CI 1.03–1.21)

“We emulated a target trial of dietary interventions using data from the ASPREE cohort.”
2

Study evidence

Genetic predisposition to major depression, as measured by a PRS derived from PGC summary statistics, did not modify the association between diet quality (ultra-processed food index or anti-inflammatory diet score) and incident depressive symptoms in the ASPREE cohort.

“A polygenic score was derived using the latest Psychiatric Genomics Consortium data for major depression.”
Claim 2 of 4Not coveredThe study, published in Molecular Psychiatry, followed 7,220 adults 70 or older for a median of 5.7 years and found that people consuming four or more servings per day of ultra-processed foods had a 12% higher rate of depressive symptoms than those consuming fewer than four servings per day.View evidenceHide evidence

As stated12% higher rate of depressive symptoms

Why this verdict

The abstract-level profile supports the cohort size, age group, median follow-up, and the main UPF estimate: high UPF consumption was associated with higher risk of depressive symptoms, RR 1.12. However, the specific exposure contrast stated as “four or more servings per day” versus fewer than four servings is not present in the supplied abstract-level profile, so that precise version of the claim is not verifiable at this depth.

1

Study evidence

High ultra-processed food (UPF) consumption was associated with a higher risk of incident depressive symptoms during follow-up.RR 1.12 (95% CI 1.03–1.21)

“We emulated a target trial of dietary interventions using data from the ASPREE cohort.”
Claim 3 of 4Not coveredThe article says the findings build on a 2025 study that considered participants' genetic predisposition and inflammation status.View evidenceHide evidence

Why this verdict

The supplied profile verifies that the paper itself considered genetic predisposition via a depression polygenic risk score and inflammation via hs-CRP. It does not verify the story’s contextual statement that the findings “build on a 2025 study,” so that relationship to another study cannot be checked from the supplied abstract-level evidence.

1

Study evidence

Genetic predisposition to major depression, as measured by a PRS derived from PGC summary statistics, did not modify the association between diet quality (ultra-processed food index or anti-inflammatory diet score) and incident depressive symptoms in the ASPREE cohort.

“A polygenic score was derived using the latest Psychiatric Genomics Consortium data for major depression.”
2

Study evidence

Low-grade systemic inflammation, as measured by circulating hs-CRP, did not modify the associations between diet quality (UPF index and anti-inflammatory diet measure) and risk of depressive symptoms in the ASPREE cohort.

“Systemic inflammation was assessed using circulating high-sensitivity C-reactive protein.”
Claim 4 of 4SupportedPeople whose diets were more anti-inflammatory had a 7% lower rate of depressive symptoms than those with more pro-inflammatory diets.View evidenceHide evidence

As stated7% lower rate of depressive symptoms

Why this verdict

The profile reports that a higher anti-inflammatory diet score was associated with lower risk of incident depressive symptoms, RR 0.93, equivalent to about a 7% lower rate/risk. The story’s associational framing matches the paper profile, though the profile notes the effect is modest and the confidence interval reaches 1.00.

1

Study evidence

High ultra-processed food (UPF) consumption was associated with a higher risk of incident depressive symptoms during follow-up.RR 1.12 (95% CI 1.03–1.21)

“We emulated a target trial of dietary interventions using data from the ASPREE cohort.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Important limitation: the outcome was elevated depressive symptoms using CES-D-10 ≥8, not a clinical diagnosis of major depressive disorder.

    The story summary mostly uses 'depressive symptoms,' but the lead claim says “risk of depression.” The supplied caveats do not acknowledge that the measured outcome was symptom-threshold based rather than diagnosed depression, which is interpretation-changing.

    From Target trial emulation; longitudinal IPTW-GEE analysis

  • Important limitation: diet exposures were derived from a food frequency questionnaire and may involve measurement error or misclassification.

    The story presentation does not mention the FFQ-derived nature of the UPF and anti-inflammatory diet measures or the associated measurement limitations.

    From Target trial emulation; longitudinal IPTW-GEE analysis

  • Important limitation for the anti-inflammatory diet result: the effect was modest and the 95% confidence interval reached the null boundary, RR 0.93 (95% CI 0.86–1.00).

    The story reports the 7% lower rate but does not mention the borderline confidence interval or modest size of the association.

    From Target trial emulation; longitudinal IPTW-GEE analysis

6 things the story did carry across
  • Main design: ASPREE cohort of 7,220 adults aged 70+ followed for a median 5.7 years, analyzed as a longitudinal observational target-trial emulation with IPTW and GEE.
  • Primary finding: high ultra-processed food consumption was associated with higher risk of incident depressive symptoms, RR 1.12.
  • Primary finding: higher anti-inflammatory diet score was associated with lower risk of incident depressive symptoms, RR 0.93.
  • Effect-modification finding: genetic predisposition to depression, measured by a polygenic risk score, did not modify the diet–depressive symptoms associations.
  • Effect-modification finding: low-grade systemic inflammation, measured using hs-CRP, did not modify the diet–depressive symptoms associations.
  • Important limitation: despite target-trial emulation and weighting, this remains observational evidence and residual confounding or other bias cannot be fully excluded.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoEstimate the causal effect (target trial emulation) of diet quality (ultra-processed food consumption and anti-inflammatory diet measure) on incident depressive symptoms in older adults in the ASPREE cohort using longitudinal methods to reduce confounding/selection bias.Target trial emulation; longitudinal IPTW-GEE analysisExpand

In plain English

Target-trial emulation in the ASPREE cohort (n=7,220, age 70+; median follow-up 5.7 years) evaluated whether diet quality—measured by an ultra-processed food (UPF) index and an anti-inflammatory diet score from a food frequency questionnaire—affects risk of depressive symptoms (CES-D-10 score ≥8) using inverse probability of treatment weighting and generalized estimating equations to estimate longitudinal risk ratios. High UPF consumption was associated with higher risk of depressive symptoms, while a higher anti-inflammatory diet score was associated with lower risk; results were not modified by a polygenic score for major depression or circulating high-sensitivity C-reactive protein.

Key findings

  • High ultra-processed food (UPF) consumption was associated with a higher risk of incident depressive symptoms during follow-up.RR 1.12 (95% CI 1.03–1.21)
  • A higher anti-inflammatory diet score was associated with a lower risk of incident depressive symptoms.RR 0.93 (95% CI 0.86–1.00)
“We emulated a target trial of dietary interventions using data from the ASPREE cohort.”
What this piece can’t prove
  • Study population restricted to older adults (age 70+), limiting generalizability to younger groups.
  • Diet exposures derived from a food frequency questionnaire, which may incur measurement error or misclassification.
  • Outcome (CES-D-10 ≥8) identifies elevated depressive symptoms rather than a clinical diagnosis of major depressive disorder.
  • Although inverse probability weighting was used to address measured confounding and selection, residual confounding and other biases inherent to observational emulations of trials cannot be fully excluded.
  • Abstract does not provide full methodological details (e.g., IPTW model covariates, diagnostics, or power for interaction tests).
2human in vivoTest whether genetic predisposition to depression (polygenic risk score) modifies the association/effect of diet quality on depressive symptoms.PRS effect-modification analysisExpand

In plain English

Within the ASPREE target-trial emulation of diet quality and depressive symptoms in older adults (n=7,220; median follow-up 5.7 years), the authors derived a polygenic risk score (PRS) for major depression from Psychiatric Genomics Consortium GWAS summary statistics and tested whether genetic predisposition modified the association between diet quality (ultra-processed food index and anti-inflammatory diet measure) and incident depressive symptoms (CES-D10 ≥8). They report that genetic predisposition did not modify the observed associations.

Key findings

  • Genetic predisposition to major depression, as measured by a PRS derived from PGC summary statistics, did not modify the association between diet quality (ultra-processed food index or anti-inflammatory diet score) and incident depressive symptoms in the ASPREE cohort.
“A polygenic score was derived using the latest Psychiatric Genomics Consortium data for major depression.”
What this piece can’t prove
  • No information in abstract on how PRS was coded (continuous vs. categories) or integrated into IPTW/GEE models.
  • Power for interaction tests in older-adult sample is not described; null modification finding could reflect limited power rather than true absence of effect modification.
  • Abstract does not present stratified effect estimates by PRS strata or full interaction model outputs, limiting assessment of consistency across subgroups.

1 further detail could not be confirmed from the summary.

3human in vivoTest whether low-grade systemic inflammation (high-sensitivity C-reactive protein) modifies the association/effect of diet quality on depressive symptoms.Target-trial emulation (ASPREE) with effect-modification analysis by hs-CRPExpand

In plain English

Within an ASPREE target-trial emulation of diet quality and depressive symptoms in adults aged 70+, the authors tested whether low-grade systemic inflammation (circulating high-sensitivity C-reactive protein, hs-CRP) modified the association between diet quality (ultra-processed food index and anti-inflammatory diet measure) and incident depressive symptoms (CES-D-10 ≥8). The abstract reports that low-grade inflammation did not modify the observed associations.

Key findings

  • Low-grade systemic inflammation, as measured by circulating hs-CRP, did not modify the associations between diet quality (UPF index and anti-inflammatory diet measure) and risk of depressive symptoms in the ASPREE cohort.
“Systemic inflammation was assessed using circulating high-sensitivity C-reactive protein.”
What this piece can’t prove
  • Abstract lacks reporting of hs-CRP assay details, thresholds/cutpoints, and whether hs-CRP was measured at baseline only or repeatedly.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

And 9 more candidates considered.